Fungemia Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 55

Fungemia Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2017” provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Histogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen's proprietary technologies are used in various applications which include hair regrowth and skincare; therapeutics including orthopedics and oncology. The company's products are stabilized and bioactive in a biocompatible liquid formula. Its products are used as research tools for stem cell growth and therapeutics. It offers products to biotechnology companies and medical research institutes. Histogen is headquartered in San Diego, California, the US. Histogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile pr......
$250

Innovate Biopharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Innovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company's pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase II for inflammatory bowel disorders, mild to moderate ulcerative colitis. Its MRCP is a clinical imaging method developed for the visualization of pancreatic ducts, and its secretin stimulated MRCP is a non-invasive, ionizing, radiation-free assessment of the pancreaticobiliary system. The company has patents across the US, Japan and other countries. Innovate is headquartered in Raleigh, North Carolina, the US. Innovate Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alli......
$250

MGB Biopharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MGB Biopharma Ltd (MGB) is a clinical stage biopharmaceutical company which develops anti-infective medicine of minor groove binder (MGBs) compounds. The company focuses on the development of new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. It offers its lead drug candidate, MGB-BP-3 in the field of antibacterial resistance. The company provides programmes which include Oral, gram-positive IV, topical, gram negative, anti-fungal, anti-viral, anti-parasitic. It provides anti-infective platform solutions to deliver drugs against multi-resistant Gram-negative pathogens, viruses, fungi and parasitic diseases. The company seeks to work in partnership with research institutes and pharmaceutical companies in the antibiotics ......
$250

Kindred Healthcare Inc (KND) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kindred Healthcare Inc (Kindred Healthcare) is a healthcare services provider with focus on post-acute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operates transitional care (TC) hospitals, inpatient rehabilitation hospitals (IRFs), community care business, assisted living facilities, nursing centers, a contract rehabilitation services business and a home health and hospice business in the US. It offers community care services such as personal care (bathing and grooming), meal preparation, companionship, light housekeeping, shopping, respite care, and transportation. Kindred Healthcare is headquartered in Louisville, Kentucky, the US. Kindr......
$250

NovoCure Ltd (NVCR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company's pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellular carcinoma, breast cancer and small cell lung cancer, among others. It also offers products for other indications such as glioblastoma and diagnosed glioblastoma. Novocure operates along with its subsidiaries located in New Hampshire, the US; and Berlin, Germany. The company owns and operates a research centre in Haifa, Israel. It also has presence in Japan and Switzerland. NovoCure is headquartered in Jersey, the UK. NovoCure Ltd (NVCR) - Pharmaceuticals & Healthcare - Deals and Allianc......
$250

AbbVie Inc (ABBV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology and general medicine therapy areas. Its products are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, osteoarthritis, plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, systemic lupus erythematosus, chronic lymphocytic leukemia, small cell lung cancer, relapsed/refractory marginal zone lymphoma, Alzheimer's disease, multiple sclerosis, Parkinson's disease, hepatitis C (HCV), human immunodeficiency vi......
$250

China Resources Pharmaceutical Group Ltd (3320) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise chemical medicines, TCMs, biologics, and health food and traditional Chinese medicine, and nutritional products. CR Pharma offers products in forms of oral solid dosage, large infusion bags, powder vials, oral liquid dosage, injections, and topical preparations. The company markets its products through logistics, wholesale, retail and supply chain services in different provinces across China. CR Pharma is headquartered in Hong Kong. China Resources Pharmaceutical Group Ltd (3320) - Pharmaceu......
$250

Mymetics Corp (MYMX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respiratory syncytial virus (RSV). Mymetics uses its proprietary technology which deploys virosomes and lipid-based carriers containing viral proteins and natural membrane proteins, in combination with rationally designed antigens or adjuvants to develop vaccines. Its vaccines are designed to induce protection against early transmission and infection. The company has subsidiaries in the Netherlands and Switzerland. It has a research and development facility in Leiden, the Netherlands. Mymetics is ......
$250

St. George’s University of London – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university's undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthcare practice foundation degree, biomedical science foundation degree, breast imaging foundation degree, healthcare science and medicine MBBS. It provides post graduate courses such as biomedical science MRes, clinical practice MRes, medical imaging, nursing, oncology practice PgCert, physician associate studies postgraduate diploma, physiotherapy MSc and social work PgDip. SGUL conducts research in the field of cardiovascular and cell sciences, infection and immunity and population health. Th......
$250

Eunice Kennedy Shriver National Institute of Child Health and Human Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the fields of fields of reducing infant deaths, improving health of women, men and families learning. It offers research in clinical trials and clinical research, health education campaigns and programs, NICHD publications, scientific research planning and scientific resources. NICHD also provides funding support for training and career development activities at universities and other institutions. The institute offers its services for laboratory research, clinical trials and studies. NICHD is he......
$250